4//SEC Filing
Waldman Louis S. 4
Accession 0000898432-20-000116
CIK 0001325618other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 5:32 PM ET
Size
15.0 KB
Accession
0000898432-20-000116
Insider Transaction Report
Form 4
IRADIMED CORPIRMD
Waldman Louis S.
Controller
Transactions
- Sale
Common Stock
2020-02-12$25.48/sh−4,307$109,742→ 0 total - Exercise/Conversion
Common Stock
2020-02-12$1.29/sh+8,750$11,288→ 8,750 total - Exercise/Conversion
Common Stock
2020-02-12$1.29/sh+17,500$22,575→ 26,250 total - Exercise/Conversion
Common Stock
2020-02-12$1.48/sh+8,750$12,950→ 35,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-02-12+8,750→ 0 totalExercise: $1.29→ Common Stock (8,750 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2020-02-12+17,500→ 0 totalExercise: $1.29→ Common Stock (17,500 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2020-02-12+8,750→ 0 totalExercise: $1.48→ Common Stock (8,750 underlying)
Footnotes (4)
- [F1]This transaction was executed in multiple trades at prices ranging from $25.43 to $25.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This option was granted on 11/20/2012 and is fully vested and exercisable.
- [F3]This option was granted on 12/13/2013 and is fully vested and exercisable.
- [F4]This option was granted on 12/31/2013 and is fully vested and exercisable.
Documents
Issuer
IRADIMED CORP
CIK 0001325618
Entity typeother
Related Parties
1- filerCIK 0001613666
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 5:32 PM ET
- Size
- 15.0 KB